Table 2.
The top 12 enriched GO terms for DRGs.
| GO-BP Term | pvalue | qvalue | gene |
|---|---|---|---|
| lymphocyte chemotaxis | 3.43E-09 | 2.12E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| monocyte chemotaxis | 4.76E-09 | 2.12E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| mononuclear cell migration | 1.95E-08 | 5.80E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| chemokine-mediated signaling pathway | 3.4E-08 | 5.87E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| lymphocyte migration | 3.67E-08 | 5.87E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| neutrophil chemotaxis | 3.95E-08 | 5.87E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| cellular response to interleukin-1 | 4.91E-08 | 6.25E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| neutrophil migration | 6.05E-08 | 6.25E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| myeloid leukocyte migration | 6.31E-08 | 6.25E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5/AZU1 |
| granulocyte chemotaxis | 1.09E-07 | 9.41E-06 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |
| cellular response to tumor necrosis factor | 1.16E-07 | 9.41E-06 | APOB/CCL11/CCL16/CCL18/CCL23/CCL8CCL5/BRCA1 |
| granulocyte migration | 1.84E-07 | 1.36E-05 | CCL11/CCL16/CCL18/CCL23/CCL8/CCL5 |